HIGHLIGHTS
- who: Mu00e9lanie Bourgin et al. from the Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France have published the article: Diagnostic, Prognostic and Mechanistic Biomarkers of COVID-19 Identified by Mass Spectrometric Metabolomics, in the Journal: Metabolites 2023, 342 of /2023/
- what: Over the past decades, metabolomic approaches have continuously been refined, thus allowing for ever more complete coverage of the metabolome.
- how: The authors identified mass metabolomic studies on specimens from SARS-CoV2-infected patients and subjected them to a cross-study comparison. The authors compared the clinical design technical aspects . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.